GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 362 filers reported holding GLOBUS MED INC in Q2 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $236 | -17.8% | 4,768 | -1.1% | 0.02% | -16.7% |
| Q2 2023 | $287 | +5.5% | 4,822 | +0.6% | 0.02% | 0.0% |
| Q1 2023 | $272 | -23.6% | 4,793 | 0.0% | 0.02% | -27.3% |
| Q4 2022 | $356 | -99.9% | 4,793 | +3.9% | 0.03% | +22.2% |
| Q3 2022 | $275,000 | +6.2% | 4,613 | 0.0% | 0.03% | +12.5% |
| Q2 2022 | $259,000 | -24.0% | 4,613 | 0.0% | 0.02% | -11.1% |
| Q1 2022 | $341,000 | +6.6% | 4,613 | +4.0% | 0.03% | +8.0% |
| Q4 2021 | $320,000 | -5.0% | 4,436 | +1.0% | 0.02% | -10.7% |
| Q3 2021 | $337,000 | -1.2% | 4,394 | -0.2% | 0.03% | +3.7% |
| Q2 2021 | $341,000 | +21.4% | 4,403 | -3.5% | 0.03% | +12.5% |
| Q1 2021 | $281,000 | +7.3% | 4,561 | +13.6% | 0.02% | -4.0% |
| Q4 2020 | $262,000 | +18.6% | 4,014 | -10.0% | 0.02% | +4.2% |
| Q3 2020 | $221,000 | +4.7% | 4,460 | -10.2% | 0.02% | -14.3% |
| Q1 2020 | $211,000 | – | 4,968 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pembroke Management, LTD | 584,085 | $43,379,993 | 4.64% |
| Sterling Investment Advisors, Ltd. | 167,023 | $12,404,798 | 4.44% |
| Ophir Asset Management Pty Ltd | 306,871 | $22,791,309 | 4.38% |
| Godshalk Welsh Capital Management, Inc. | 72,285 | $5,368,607 | 3.92% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 672,400 | $49,939,148 | 3.30% |
| Provident Investment Management, Inc. | 362,745 | $26,941,071 | 3.19% |
| XXEC, Inc. | 97,600 | $7,248 | 2.91% |
| Van Berkom & Associates Inc. | 809,945 | $60,155 | 2.58% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,424,326 | $105,784,692 | 2.38% |
| Seaport Global Advisors, LLC | 7,647 | $567,943 | 1.97% |